Don't miss a thing!
OUR NEWS AND VIEWS
SHARING LATEST
DEVELOPMENTS AND INSIGHTS
Here we report on topics relating to digital medical publishing and our business. These include our research reports, whitepapers and thought-leadership, as well as our latest programmes, engagement insights, industry partnerships and team recruits.
Nov 2023
Webinar recording: Cutting Through the Noise with Impactful HCP Education
This MedComms Networking webinar saw EPG Health collaborate with a panel of industry experts to discuss new research into HCP content and channel preferences for medical education, and approaches to measuring meaningful outcomes.
ACCESS THE RECORDINGNov 2023
NEW RESEARCH REPORT: The Future of HCP Engagement Impact
Understanding HCP needs and behaviour and developing meaningful impact metrics are among pharma’s top HCP engagement priorities for 2024, EPG Health’s latest research reveals.
Learn MoreSep 2023
Celebrating best practice at the PM Society Digital Awards
EPG Health was recognised by the PM Society at its Digital Awards in London on 14 September. The independent Supportive Care in Oncology Learning Zone, hosted on Medthority, was a finalist in the HCP Education category.
Learn MoreFeatured article
Thought Leadership
Creating an award-winning HCP engagement platform
EPG Health’s pioneering approach to…
Jan 2023
May 2023
Supportive Care in Oncology programme drives knowledge change
Overwhelming intent to change clinical practice has been recorded among healthcare professionals engaging with a Supportive Care in Oncology Learning Zone hosted on Medthority.
Learn MoreMay 2023
Growth Hormone Deficiency Learning Zone launches on Medthority
HCPs will gain understanding of growth hormone deficiency and appropriate treatment options after engaging with this educational programme, developed independently of sponsor Sandoz.
View the Learning ZoneMay 2023
Programme goes live: Anti-CGRP therapies for migraine
Developed with an educational grant from Pfizer, this Learning Zone includes focus on the unmet needs and disease burden associated with migraine and anti-CGRP therapies for acute and prophylactic treatment.
View the Learning Zone